These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 38791164)

  • 21. Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling.
    Czaya B; Heitman K; Campos I; Yanucil C; Kentrup D; Westbrook D; Gutierrez O; Babitt JL; Jung G; Salusky IB; Hanudel M; Faul C
    Elife; 2022 Mar; 11():. PubMed ID: 35302487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skeletal Muscle Complications in Chronic Kidney Disease.
    Troutman AD; Arroyo E; Lim K; Moorthi RN; Avin KG
    Curr Osteoporos Rep; 2022 Dec; 20(6):410-421. PubMed ID: 36149594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The combination of vitamin D deficiency and mild to moderate chronic kidney disease is associated with low bone mineral density and deteriorated femoral microarchitecture: results from the KNHANES 2008-2011.
    Lee YH; Kim JE; Roh YH; Choi HR; Rhee Y; Kang DR; Lim SK
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3879-88. PubMed ID: 24878040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skeletal myopathy in CKD: a comparison of adenine-induced nephropathy and 5/6 nephrectomy models in mice.
    Kim K; Anderson EM; Thome T; Lu G; Salyers ZR; Cort TA; O'Malley KA; Scali ST; Ryan TE
    Am J Physiol Renal Physiol; 2021 Jul; 321(1):F106-F119. PubMed ID: 34121452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic kidney disease-induced muscle atrophy: Molecular mechanisms and promising therapies.
    Wang K; Liu Q; Tang M; Qi G; Qiu C; Huang Y; Yu W; Wang W; Sun H; Ni X; Shen Y; Fang X
    Biochem Pharmacol; 2023 Feb; 208():115407. PubMed ID: 36596414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sarcopenia and relationships between muscle mass, measured glomerular filtration rate and physical function in patients with chronic kidney disease stages 3-5.
    Zhou Y; Hellberg M; Svensson P; Höglund P; Clyne N
    Nephrol Dial Transplant; 2018 Feb; 33(2):342-348. PubMed ID: 28340152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catabolic signaling and muscle wasting after acute ischemic stroke in mice: indication for a stroke-specific sarcopenia.
    Springer J; Schust S; Peske K; Tschirner A; Rex A; Engel O; Scherbakov N; Meisel A; von Haehling S; Boschmann M; Anker SD; Dirnagl U; Doehner W
    Stroke; 2014 Dec; 45(12):3675-83. PubMed ID: 25352483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical relevance of sarcopenia in chronic kidney disease.
    Moorthi RN; Avin KG
    Curr Opin Nephrol Hypertens; 2017 May; 26(3):219-228. PubMed ID: 28198733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for muscle wasting and dysfunction in patients with chronic kidney disease.
    Carrero JJ; Johansen KL; Lindholm B; Stenvinkel P; Cuppari L; Avesani CM
    Kidney Int; 2016 Jul; 90(1):53-66. PubMed ID: 27157695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity causes renal mitochondrial dysfunction and energy imbalance and accelerates chronic kidney disease in mice.
    Andres-Hernando A; Lanaspa MA; Kuwabara M; Orlicky DJ; Cicerchi C; Bales E; Garcia GE; Roncal-Jimenez CA; Sato Y; Johnson RJ
    Am J Physiol Renal Physiol; 2019 Oct; 317(4):F941-F948. PubMed ID: 31411075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uraemic sarcopenia: aetiology and implications.
    Fahal IH
    Nephrol Dial Transplant; 2014 Sep; 29(9):1655-65. PubMed ID: 23625972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with fibroblast growth factor 19 increases skeletal muscle fiber size, ameliorates metabolic perturbations and hepatic inflammation in 5/6 nephrectomized mice.
    Benoit B; Beau A; Bres É; Chanon S; Pinteur C; Vieille-Marchiset A; Jalabert A; Zhang H; Garg P; Strigini M; Vico L; Ruzzin J; Vidal H; Koppe L
    Sci Rep; 2023 Apr; 13(1):5520. PubMed ID: 37015932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial Activity and Skeletal Muscle Insulin Resistance in Kidney Disease.
    Carré JE; Affourtit C
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis.
    Meyer F; Bannert K; Wiese M; Esau S; Sautter LF; Ehlers L; Aghdassi AA; Metges CC; Garbe LA; Jaster R; Lerch MM; Lamprecht G; Valentini L
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sarcopenia in cirrhosis: from pathogenesis to interventions.
    Ebadi M; Bhanji RA; Mazurak VC; Montano-Loza AJ
    J Gastroenterol; 2019 Oct; 54(10):845-859. PubMed ID: 31392488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal Protein Intake in Pre-Dialysis Chronic Kidney Disease Patients with Sarcopenia: An Overview.
    Isaka Y
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33917381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs.
    Solagna F; Tezze C; Lindenmeyer MT; Lu S; Wu G; Liu S; Zhao Y; Mitchell R; Meyer C; Omairi S; Kilic T; Paolini A; Ritvos O; Pasternack A; Matsakas A; Kylies D; Wiesch JSZ; Turner JE; Wanner N; Nair V; Eichinger F; Menon R; Martin IV; Klinkhammer BM; Hoxha E; Cohen CD; Tharaux PL; Boor P; Ostendorf T; Kretzler M; Sandri M; Kretz O; Puelles VG; Patel K; Huber TB
    J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 34060483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
    Biolo G; Cederholm T; Muscaritoli M
    Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between Stage of Chronic Kidney Disease and Sarcopenia in Korean Aged 40 Years and Older Using the Korea National Health and Nutrition Examination Surveys (KNHANES IV-2, 3, and V-1, 2), 2008-2011.
    Moon SJ; Kim TH; Yoon SY; Chung JH; Hwang HJ
    PLoS One; 2015; 10(6):e0130740. PubMed ID: 26083479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced oxidation protein products contribute to chronic kidney disease-induced muscle atrophy by inducing oxidative stress via CD36/NADPH oxidase pathway.
    Kato H; Watanabe H; Imafuku T; Arimura N; Fujita I; Noguchi I; Tanaka S; Nakano T; Tokumaru K; Enoki Y; Maeda H; Hino S; Tanaka M; Matsushita K; Fukagawa M; Maruyama T
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1832-1847. PubMed ID: 34599649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.